Illumina reported $1.1B in revenue (+4.2% YoY), compared with a +20.6% median across covered Information Technology peers. Insider tracks 1 open management expectation for this company. 3 insider sales recorded.
Illumina, Inc. saw significant stock transactions by company leadership and institutional investors this week. Director Keith A. Meister sold 280,091 shares, Corvex Management LP filed a notice of a proposed sale of 375,000 shares, and Capital World Investors reported a 6.7% stake.
From October 31 to November 6, company executives and directors reported share transactions. This review covers market operations and plans to sell securities. Such disclosures are a technical requirement and do not allow for an assessment of insider sentiment or future company results.
Illumina, Inc. reported financial results for the third quarter of 2026, with revenue of $1.13 billion, up 4.2% from the same period last year. Earnings exceeded guidance due to healthy clinical demand and robust NovaSeq X placements.
On October 8, 2026 Illumina, Inc. signed definitive documentation establishing an unsecured commercial paper program that allows issuance of short‑term notes up to $1.0 billion, and to date none of those notes are outstanding
ILLUMINA, INC.: 12 recorded developments from 3 official sources in 2026-10.
2026-10-13: Offers and sales of the Notes shall be made only to investors that the Dealer reasonably believes are Qualified Institutional Buyers or Institutional Accredited Investors, and to non‑bank fiduciaries purchasing for accounts also believed to be qualified.Source
2026-10-13: On October 8, 2026, Illumina, Inc. entered into definitive documentation to establish an unsecured commercial paper program (the CP Program) pursuant to which the Company may issue short-term, unsecured commercial paper notes (the CP Notes) pursuant to the exemption from registration conSource
2026-10-13: Amounts available under the CP Program may be borrowed, repaid and re-borrowed from time to time, with the aggregate principal amount of CP Notes outstanding under the CP Program at any time not to exceed $1.0 billion.Source
2026-10-13: As of the date of this report, no CP Notes were outstanding under the CP Program.Source
2026-10-13: The maturities of the CP Notes will vary but may not exceed 397 days from the date of issue.Source
2026-10-13: Initially, three commercial paper dealers will each act as a dealer under the CP Program (each a Dealer and, collectively, the Dealers) pursuant to the terms and conditions of a commercial paper dealer agreement entered into among the Company and each Dealer (each, a Dealer Agreement).Source
2026-10-13: A national bank will act as issuing and paying agent under the CP Program.Source
2026-10-13: Each Dealer Agreement provides the terms under which the applicable Dealer will either purchase the CP Notes from the Company or arrange for the sale of the CP Notes by the Company to one or more purchasers, in each case pursuant to an exemption from federal and state securities laws.Source
2026-10-13: From time to time, one or more of the Dealers and certain of their respective affiliates have provided, and may in the future provide, commercial banking, investment banking and other financial advisory services to the Company and its affiliates for which they have received or will receiSource
2026-10-13: The CP Notes have not been and will not be registered under the Securities Act or state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.Source
2026-10-13: If the Dealer arranges a sale of the Notes, the transaction will be based on terms agreed by the Dealer and the Issuer.Source
2026-10-29: Illumina, Inc. issued a press release on October 29, 2026, announcing financial results for the third quarter ended September 27, 2026.Source
Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.
Key figures
From the 10-Q for the period ended September 27, 2026, filed October 30, 2026. SEC
Latest
Earlier
Change
Revenue quarter
$1.1B
$1.1B
+4.2%
Operating income quarter
$305M
$227M
+34.4%
Net income quarter
$220M
$150M
+46.7%
Diluted EPS quarter
$1.43
$0.98
+45.9%
Operating cash flow year to date
$909M
$758M
+19.9%
Next results expected around January 29, 2027 (estimate: the quarter ending about December 27, 2026 plus the 33 days the last report took). The company announces the actual date.
As the company tagged them in its filing (SEC XBRL). Quarter and year figures are compared with the same period a year earlier, balances with the previous balance sheet. Download CSV
Revenue by quarter, $B
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.
Sector peers
How this company compares with 89 covered companies in Information Technology (median revenue change +20.6% YoY), from archived SEC XBRL filings.
AI assessment, provisional no new evidence in later reports yet (as of November 16, 2026) · Later article
What management said to expect (targets, plans, forecasts) in the company's own documents (in English, as extracted), with the date and the period it named. Assessments are written by AI from the company's later reports: provisional, not checked by an editor, and a consistent later report is not proof. An editor's decision replaces them.
From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.